Imagine having a microscope so powerful it can see the tiny magnetic pulses of a heart cell without touching it. This project uses special diamonds and laser light to create a high-definition map of how heart cells behave. It's like switching from a blurry old photo to a 4K video to see exactly where a heart rhythm goes wrong.
Current medical imaging lacks the sensitivity and resolution to non-invasively map the magnetic and electric activity of heart cells, making it difficult to diagnose and treat complex arrhythmias.
A quantum magnetic sensing platform using diamond NV centers and quantum-enhanced infrared light sources for biological imaging.
If you are a diagnostic equipment manufacturer dealing with the limits of classical imaging resolution — this project developed quantum magnetic sensing based on NV centers in diamond that provides non-invasive, high-resolution mapping of cardiac activity.
If you are a drug developer dealing with the difficulty of tracking how new medicines affect heart cell proteins — this project developed quantum frequency combs and infrared lasers that detect cell-membrane proteins below the quantum noise limit.
If you are a biotech provider dealing with imprecise measurements of cardiac arrhythmias — this project developed a hybrid sensor that reveals both magnetic and electric fields in cardiac-cell activity simultaneously.
Based on available project data, specific unit costs or pricing models are not provided; the project focuses on development and feasibility studies for industrialization.
The project includes a specific goal to perform a feasibility study of the industrialization of these quantum technologies to move from components to a commercial roadmap.
Based on available project data, specific licensing terms are not mentioned, but the consortium includes 5 industry partners to facilitate the move toward industrial exploitation.
The project period runs from 2022-07-01 to 2027-06-30, suggesting that validated prototypes and industrial roadmaps will be available by mid-2027.
The project develops hybrid sensors that combine quantum magneto-microscopy with optical imaging, designed to be non-invasive for biological samples.
The consortium is well-balanced for technology transfer, featuring 13 partners across 6 countries. With an industry ratio of 38% (including 5 industry partners and 3 SMEs), there is a strong commercial pull to ensure the research translates into viable products, supported by 5 universities and 3 research institutions.
Contact the Consiglio Nazionale delle Ricerche (CNR) in Italy
Contact SciTransfer for a detailed analysis of the quantum sensing IP portfolio.
